Lung Cancer Drug Fails To Meet Endpoints
Ligand Pharmaceuticals' lung cancer drug, Targretin, didn't meet endpoints of improved overall survival in two Phase III studies.
network
Ligand Pharmaceuticals' lung cancer drug, Targretin, didn't meet endpoints of improved overall survival in two Phase III studies.
...and call center employees shouldn't supervise ad campaigns. Since this company just contacted me by accident trying to reach either Google or Overture, now I get to trash their website.
Infoworld has written an article on a comprehensive package on the use of blogs/wikis in internal communications as well as for corporate communications/PR.
Steve is Vice President Client Solutions at CooperKatz, a New York PR firm, and author of the Micro Persuasion blog. He is arguably the most prominent and influential blogger in the PR profession either side of the Atlantic.
Toshiba was ordered by a California jury to pay $84 million in punitive damages to Lexar.
A Yahoo spokesperson has confirmed that Yahoo Messenger is the target of a phishing attack.